JULIE GASTIER-FOSTER to Safety
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Safety.
Connection Strength
0.037
-
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer. 2019 06; 66(6):e27681.
Score: 0.037